---
type: "Symbol"
title: "Genrix Bio (688443.SH) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/688443.SH/topics.md"
symbol: "688443.SH"
parent: "https://longbridge.com/en/quote/688443.SH.md"
count: 3
datetime: "2026-03-16T15:05:20.039Z"
locales:
  - [en](https://longbridge.com/en/quote/688443.SH/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688443.SH/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688443.SH/topics.md)
---

# Genrix Bio (688443.SH) — Community Discussions

### [Cansino Biologics has reached a cooperation agreement on two innovative biologics for passive immunization against tetanus and rabies.](https://longbridge.com/en/topics/34387234.md)

- Author: [亚太商讯那些事儿](https://longbridge.com/en/profiles/18018177.md)
- Datetime: 2025-09-23T15:16:41.000Z
- Comments: 0
- CSPC Pharmaceutical Group Limited ("CSPC Pharma") is pleased to announce that on September 22, 2025, through its subsidiary, it has entered into exclusive collaboration agreements ("Agreem

### [科创板第五套上市标准收紧，创新药企路在何方？](https://longbridge.com/en/topics/11756524.md)

- Author: [锦缎研究院](https://longbridge.com/en/profiles/2576456.md)
- Datetime: 2024-02-26T03:52:09.000Z
- Comments: 0
- 中国医药产业正处于有史以来最严酷的寒冬之中。伴随资本市场中医药公司市值的不断下降，投资者也开始怀疑人生，不禁发出中国医药产业路在何方的感叹。2022 年推出的《科创板第五套上市标准》曾被认为是 A 股的 “18A”，允许突破关键核心技术、拥有原创引领技术，但处于研发阶段尚未形成收入的企业上市，这对于支持中国医药产业创新转型起到了积极作用。然而，由于 A 股历来看重企业盈利能力...

### [国产银屑病赛道 IL-17 即将打破外资多寡头格局，恒瑞、丽珠、智翔金泰谁将破局？](https://longbridge.com/en/topics/10152161.md)

- Author: [药械Talks](https://longbridge.com/en/profiles/6059509.md)
- Datetime: 2023-10-10T12:45:10.000Z
- Comments: 0
- 有这样一种疾病，被称为 “不死的癌症”，那便是银屑病。由于病因复杂，目前尚未有完全治愈银屑病的药物获批上市，大多数患者需要长期治疗，甚至终身服药。尤其是，患者人数相当庞大，全球至少已有 6000 万银屑病患者，仅中国就有超过 700 万人。在众多治疗药物中，疗效更佳的 IL-17 抑制剂深受市场关注。随着智翔金泰、恒瑞医药等国产药企即将进入市场，将有望打破诺华和礼来等外资多寡头格局...

## References

- [Genrix Bio (688443.SH)](https://longbridge.com/en/quote/688443.SH.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/688443.SH/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688443.SH/topics.md)